BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1068 related articles for article (PubMed ID: 30466981)

  • 1. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin.
    Li H; Krstin S; Wang S; Wink M
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
    Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
    Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells.
    Su S; Cheng X; Wink M
    Phytomedicine; 2015 Feb; 22(2):301-7. PubMed ID: 25765837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
    Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
    Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites.
    Zhou JX; Wink M
    Medicines (Basel); 2018 Nov; 5(4):. PubMed ID: 30428619
    [No Abstract]   [Full Text] [Related]  

  • 7. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters.
    Eid SY; El-Readi MZ; Wink M
    Phytomedicine; 2012 Aug; 19(11):977-87. PubMed ID: 22770743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells.
    Eid SY; El-Readi MZ; Wink M
    Phytomedicine; 2012 Nov; 19(14):1288-97. PubMed ID: 23146422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
    Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
    Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols.
    Jodoin J; Demeule M; Beliveau R
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):149-59. PubMed ID: 11853888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
    Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
    Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31.
    Sun W; Wong ILK; Law HK; Su X; Chan TCF; Sun G; Yang X; Wang X; Chan TH; Wan S; Chow LMC
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
    Sun YF; Wink M
    Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
    Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.